Actinium Pharmaceuticals, Inc. (NYSE: ATNM) announced that the Company has initiated the European Medicines Agency (EMA) Scientific Advice process for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE